These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


124 related items for PubMed ID: 145518

  • 1. Risks of BCG intralesional therapy: an experience with melanoma.
    Robinson JC.
    J Surg Oncol; 1977; 9(6):587-93. PubMed ID: 145518
    [Abstract] [Full Text] [Related]

  • 2. Immunotherapy of melanoma with BCG: two fatalities following intralesional injection.
    McKhann CF, Hendrickson CG, Spitler LE, Gunnarsson A, Banerjee D, Nelson WR.
    Cancer; 1975 Feb; 35(2):514-20. PubMed ID: 234291
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Intralesional treatment of recurrent metastatic cutaneous malignant melanoma: a randomized prospective study of intralesional Bacillus Calmette-Guerin versus intralesional dinitrochlorobenzene.
    Cohen MH, Jessup JM, Felix EL, Weese JL, Herberman RB.
    Cancer; 1978 Jun; 41(6):2456-63. PubMed ID: 657108
    [Abstract] [Full Text] [Related]

  • 6. Severe complications of intralesional BCG therapy in an unsensitized patient. Case report and clinical implications.
    Felix EL, Jessup JM, Cohen MH.
    Arch Surg; 1978 Jul; 113(7):893-6. PubMed ID: 678104
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Intralesional BCG application in malignant melanoma.
    Sopková B, Kolár V.
    Neoplasma; 1976 Jul; 23(4):421-6. PubMed ID: 794745
    [Abstract] [Full Text] [Related]

  • 9. Immunotherapy in patients with melanoma.
    Seiger HF, Shingleton WW, Metzgar RS, Buckley CE.
    Ann Surg; 1973 Sep; 178(3):352-9. PubMed ID: 4269702
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hazards and complications of BCG immunotherapy.
    Sparks FC.
    Med Clin North Am; 1976 May; 60(3):499-509. PubMed ID: 1271890
    [Abstract] [Full Text] [Related]

  • 13. Complete remission of metastatic malignant melanoma following immunotherapy with Bacillus Calmette-Guerin (BCG): report of a case.
    Coates AS, Peters M.
    Aust N Z J Surg; 1977 Jun; 47(3):362-5. PubMed ID: 269705
    [Abstract] [Full Text] [Related]

  • 14. Immunotherapy of melanoma with intralesional BCG.
    Bornstein RS, Mastrangelo MJ, Sulit H, Chee D, Yarbro JW, Prehn LM, Prehn RT.
    Natl Cancer Inst Monogr; 1973 Dec; 39():213-20. PubMed ID: 4595320
    [No Abstract] [Full Text] [Related]

  • 15. Experience with BCG adjuvant immunotherapy in stage II malignant melanoma.
    Deutschmann KE, Peter HH, Schultheis W, Deicher H.
    Tumori; 1977 Dec; 63(3):303-7. PubMed ID: 898298
    [Abstract] [Full Text] [Related]

  • 16. Intralesional immunotherapy of melanoma with BCG.
    Rosenberg SA, Rapp HJ.
    Med Clin North Am; 1976 May; 60(3):419-30. PubMed ID: 1271887
    [Abstract] [Full Text] [Related]

  • 17. BCG immunotherapy as a systemic adjunct to surgery in malignant melanoma.
    Morton DL, Eilber FR, Holmes EC, Sparks FC, Ramming K.
    Med Clin North Am; 1976 May; 60(3):431-9. PubMed ID: 1271888
    [Abstract] [Full Text] [Related]

  • 18. A Phase II study of autologous irradiated tumor cells plus BCG in patients with metastatic malignant melanoma.
    Laucius JF, Bodurtha AJ, Mastrangelo JM, Bellet RE.
    Cancer; 1977 Nov; 40(5):2091-3. PubMed ID: 336181
    [Abstract] [Full Text] [Related]

  • 19. Effectiveness of systemic BCG therapy in advanced melanoma.
    El-Domeiri AA, Nika B, Hsia WC, Crispen R, Sabet TY, Gupta TK.
    Arch Surg; 1977 Mar; 112(3):257-9. PubMed ID: 843215
    [Abstract] [Full Text] [Related]

  • 20. Regression of pulmonary metastatic disease associated with intralesional BCG therapy of intracutaneous melanoma metastases.
    Mastrangelo MJ, Bellet RE, Berkelhammer J, Clark WH.
    Cancer; 1975 Oct; 36(4):1305-8. PubMed ID: 1175129
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.